Published by
@ShahidNShah
@ShahidNShah
iSpecimen Expands COVID-19 Research with Sequences Specimens to Detect Variants
– iSpecimen, the developer of an online marketplace that connects human biospecimen with researchers, announced that is has expanded its supplier capabilities in support of COVID-19 researchers. – Through a new partnership with a reference lab in New York, researchers looking to validate their own COVID variant identification assays can obtain sequenced and unsequenced COVID-19 positive and negative swabs in a variety of media types through iSpecimen.
Continue reading at hitconsultant.net
Make faster decisions with community advice
- Blockchain built Avaneer Health network gets $50M boost from Aetna, Cleveland Clinic, others
- Digital health companies rake in $28.4B in 2021
- 3 Ways Real-Time ADT Notifications Will Benefit Payers’ Businesses
- NFT In Healthcare: How Patients Could Monetise Their Health Data
- What to know about implementing single-sign-on and multifactor authentication
Next Article
-
3 Ways Real-Time ADT Notifications Will Benefit Payers’ Businesses
But inadequacies in current payer/provider communication often disrupt the flow of timely care and lead to unnecessary hospital readmissions and poor outcomes. With real-time admission, discharge, and …
Posted Jan 14, 2022 Discharge And Reduced Admission Patient Discharge Private Payers
